Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia
Acta Neuropathol (2024) 147 (1), 14 DOI: 10.1007/s00401-023-02657-y
Probing the Interactions of LRP1 Ectodomain-Derived Peptides with Fibrillar Tau Protein and Its Impact on Cellular Internalization
Applied Sciences (2023) 13 (2), 853 DOI: 10.3390/app13020853
Biochemical analyses of tau and other neuronal markers in the submandibular gland and frontal cortex across stages of Alzheimer disease
Neurosci Lett (2023) 810, 137330 DOI: 10.1016/j.neulet.2023.137330
Molecular determinants of the crosstalk between endosomal microautophagy and chaperone-mediated autophagy
Cell Reports (2023) 42 (12), 113529 DOI: 10.1016/j.celrep.2023.113529
Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology
Science Advances (2023) 9 (19), eadf3775 DOI: 10.1126/sciadv.adf3775
Evolving prion-like tau conformers differentially alter postsynaptic proteins in neurons inoculated with distinct isolates of Alzheimer’s disease tau
Cell & Bioscience (2023) 13 (1), 174 DOI: 10.1186/s13578-023-01133-0
Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration
Brain (2023) 146 (3), 1152-1165 DOI: 10.1093/brain/awac407
Mutations in α-synuclein, TDP-43 and tau prolong protein half-life through diminished degradation by lysosomal proteases
Molecular Degeneration(2023) 18 (1), 29 DOI: 10.1186/s13024-023-00621-8
An astrocyte BMAL1-BAG3 axis protects against alpha-synuclein and tau pathology
Neuron (2023) 111 (15), 2383-2398.e7 DOI: 10.1016/j.neuron.2023.05.006
Mural cell dysfunction leads to altered cerebrovascular tau uptake following repetitive head trauma
ScienceDirect; https://doi.org/10.1016/j.nbd.2020.105237